NOTNG.COM | Healthy Blog

Posts Tagged ‘11/’

Mukesh Ambani, the eagle forte of India’s largest private sector enterprise –Reliance Industries Limited (RIL) – may be facing a bump in the road to his dream project realization, but this dynamic one is optimistic that his dream will be released soon; even if it has to switch locations.

MahaMumbai Special Economic Zone (MSEZ), a dream venture for this visionary, is a project of mammoth proportions with great potential for tremendous end results. MSEZ would have been a signature project for Maharashtra; a state that hasn’t seen projects of this degree for many years now. The development of the special economic zone in the Raigad district, a multi-product development unit, is facing termination due to bouts of some protests, but this has not hampered the dreams of Mukesh Ambani and his right hand associate Anand Jain- the duo who conceived this brainchild with immense aspirations.

The project was initially approved in the year 2005. The SEZ was to be built between the upcoming Navi Mumbai airport and Pen towards the south and Uran towards the west. Mukesh Ambani and Anand Jain had projected an investment of Rs 35,000 crore over a period of 10 to 12 years for this great leap of faith, that could have transformed not only the district’s economic stand, but could have acted as a catalyst of major growth that Maharashtra is trying to attain for some years now. Even as the state tries to follow the footsteps of ‘Vibrant Gujarat’ enterprise, this mammoth project could have been the first step to the fore.

The export potential of the entire project was calculated at around Rs 75,000 crore with 20 lakh people directly or indirectly employed. Some sources said the project could have had the potential to wipe out 20% of Maharashtra’s unemployment woes.

Nevertheless, even as the state decided to scrap this colossal project in the name of incursion, both Ambani and Jain are buoyant and positive in taking their hobbyhorse to new turfs.

Mukesh Ambani has planned an SEZ near Gurgaon and Jhajjar, that some have billed as the country’s largest. The ongoing project in Navi Mumbai is taking a magnanimous course to ascertain that the twin city and the state are reaping the benefits of development that Reliance will foster in time to come.

Mukesh Ambani, husband of Nita Ambani and his RIL leaders, Nikhil Meswani, Manoj Modi and Hital Meswani have been helping Reliance reach the top.

Everyone must have experienced at least once where they have the need for quick cash in hand, whether it is to pay for groceries, pay for emergency incidents such as hospital bills or other things. For the lucky ones, they can easily fulfill that need whenever, but for most people that life is all about living from one paycheck to another, this cannot be done. Once in a while the quick cash need can be fulfilled but what if the sum required is quite a lot?

This is where cash advance loans come in handy. Cash advance loan or also known as payday loan, is a short term loan that can be applied by anybody with fix income. There is no need to fax any documents, and no credit check is conducted either. Although the process of cash advance loan is simple, due to the many companies that are providing this type of loan, a person has to do a little research regarding which companies that have the best offer, just like when looking for life insurance quotes.

There is nothing wrong in doing small researches to obtain the best results, since the goal of looking for a loan is to help a person get out of a problem, and not going into another problem.

Most innovation in oncology over the past 10 years has been driven by scientific advances, particularly in genomics, transcriptomics and proteomics.

In the current environment, the successful oncology players of the future will be those that can anticipate protocol evolution and design the most relevant clinical trials. In recent years, biotech companies have fuelled innovation in oncology more than ever before. Partnering with biotech companies is a key (but expensive) source of innovation for many pharma companies as approximately 75% of phase II, III and pre-registration innovative drugs are of biotech origin.

At $47.7bn, cancer is one of the largest, fastest growing markets in the pharmaceutical industry. However, pricing risk remains the key investment concern in oncology. The key concern, however, is not price erosion driven by competitive forces, but price cuts imposed by payors irrespective of the fact that such unilateral price cuts by payors have never occurred in any of the major developed markets and would surely jeopardize the premise on which the entire biopharmaceutical industry has been built.

Key features of this report

• Epidemiological analysis and forecast prevalence of the major cancer indications over the period 2008-14 including lung, breast, colorectal, ovarian cancer markets.

• Forecasts and analysis of the major products in the cancer market over the period 2008-14 spread across the major indications and classes of treatments.

• Overview of key events in the global cancer market that have impacted treatment trends and sales potential across the major cancer indications.

• Strategic and growth analysis of leading pharmaceutical corporations based on sales focus by drug class, currently marketed products and R&D product portfolios.

Scope of this report

• Develop insight into patient potential with the report’s coverage of major indications in the cancer segment, the seven largest geographic pharmaceutical markets and 10 largest companies active in the cancer segment today

• Quickly understand how recent events are affecting the performance of major products, and how their marketers are confronting competitive changes in cancer marketplace

• Gain up-to-date competitive intelligence across the cancer indications and understand the major issues affecting key pharmaceutical/biotech players

• Understand which indications have the greatest potential to provide franchise growth, and how pharmaceutical companies are attempting to exploit these opportunities

Key Market Issues

• FDA approves Cervarix for cervical cancer
In October 2009, FDA approved GSK’s Cervarix for the prevention of pre-cancerous lesions caused by human papillomavirus (HPV) type 16 & 18 in women aged 10–25 years. Cervarix’s inclusion in children’s vaccine program is a major step towards securing reimbursement. Cervarix, expected to launch by the end of 2009, faces direct competition from Merck’s Gardasil and will help to reduce the incidence of cervical cancer in future.

The 12 b vitamin is one of the b vitamins that are essential to maintain a healthy body. Otherwise known as Cobalamin, the 12b vitamin is needed for the processes to convert the carbohydrates, fats and proteins from food into energy. 12 b also, more importantly, helps keep the red blood cells healthy and therefore prevent heart disease as well as keeping the immune system functioning at its maximum level. In addition, 12 b is used to create the protective covering of all nerve cells in the body.
The most important function of 12 b is to form healthy red blood cells. However, all cells need 12 b to keep them healthy. It is the white blood cells, amongst others, that need 12 b to help ensure that the immune system functioning properly. All of the nerve cells in the body also need 12 b to form their protective fatty layer. This is essential for all of the nerves but is especially so for those in the brain. If there is not sufficient 12 b to create this protective layer then the brain will not be functioning properly.
Interestingly, the amount of 12 b that the body needs is relatively small but is needed on a regular basis. However, 12 b on its own is not enough as the body cannot absorb it easily. To help the body absorb 12 b the stomach produces intrinsic factor which enables more of the 12 b to be absorbed. 12 b is only found in animal foods such as liver, eggs, fish and meat but most people consume far more than their recommended daily amount of 12 b. This is not a problem as the body can only absorb about half of the 12 b that is consumed. It is also worth noting that the body can recycle the 12 b which cuts down on the impact of a 12 b deficiency. However, strict vegetarians or vegans are likely to require 12 b supplements if they do not eat any animal products that contain 12 b.
If the body does not have enough 12 b then anaemia is the most obvious symptom. Obviously, this is due to the fact that there is not enough 12 b to make healthy red blood cells. Anaemia can also be caused by the body not creating enough intrinsic factor to help absorb the 12 b that is available in the food consumed. The body tends to makes less intrinsic factor once a person reaches 50 and this will lead to less 12 b being absorbed and supplements of 12 b may be required. Kids are also at risk from anaemia because they may not eat the food that contain 12 b. Pregnant women need more 12 b because the baby is absorbing 12 b during the pregnancy to grow properly.